Cerulean Pharma Fund Predictions

Buy CERU

*Your capital is at risk

$0.660

+0 (+0%)

At Close: Jan 16, 2018

Currently predicting for Thu, 25 Jun 2026

CERU Live board

Community Bull/Bear

Target Next close

Join the CERU prediction battle

Create a free account to see the full board, submit your call, compare with other predictors, and build a public record.

Create free account Log in

CERU Prediction Chart

Unlock the prediction chart

Registered users can inspect target prices, community averages, and how calls develop across recent sessions.

Create free account Log in

Forecast Desk

3-Month Forecasts For CERU

Forecasts map a 66-session price path from approved predictors. Log in or create a free account to view forecasts and request one for this ticker.

Create free account Log in to view forecasts

CERU Predictions History

Predictor	Target Session	Target Price	Accuracy
Community predictor	Next session	USD target	Record locked
Ranked predictor	Previous session	Bullish/Bearish	Score locked

See the prediction record

Create free account Log in

Forecast Desk

Request A 3-Month Forecast

Price path
Approved predictor
3-month horizon

Create Free Account Log In To View Forecasts

ABOUT CERULEAN PHARMA INC.

Cerulean Pharma Inc., a clinical-stage company, develops nanotechnology-based therapeutics in the areas of oncology and other diseases in the United States. The companys lead product candidate is CRLX101, a tumor targeted nanoparticle-drug conjugate (NDC), which is in Phase 2 clinical development in patients with renal cell carcinoma; and in Phase 2 and Phase 1b clinical development in patients with ovarian cancer. It is also developing CRLX301...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
NESR $25.06	0.439%	Jun 22
IDYA $28.98	25.19%	Jun 12
PHM $118.49	14.53%	Jun 10
DHI $146.71	13.50%	Jun 10
EAT $140.46	20.94%	Jun 05

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by